Bernd Holleczek

25.4k total citations · 2 hit papers
237 papers, 8.0k citations indexed

About

Bernd Holleczek is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bernd Holleczek has authored 237 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Oncology, 46 papers in Pathology and Forensic Medicine and 42 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bernd Holleczek's work include Global Cancer Incidence and Screening (45 papers), Colorectal Cancer Screening and Detection (39 papers) and Cancer survivorship and care (23 papers). Bernd Holleczek is often cited by papers focused on Global Cancer Incidence and Screening (45 papers), Colorectal Cancer Screening and Detection (39 papers) and Cancer survivorship and care (23 papers). Bernd Holleczek collaborates with scholars based in Germany, United States and Ireland. Bernd Holleczek's co-authors include Hermann Brenner, Ben Schöttker, Kai-Uwe Saum, Laura Perna, Lina Jansen, Alexander Katalinic, Andrea Eberle, Ádám Gondos, Volker Arndt and Ute Mons and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Bernd Holleczek

229 papers receiving 7.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort

2016 395 citations Laura Perna, Ute Mons et al. Clinical Epigenetics profile →
Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers

2023 66 citations Hannah Stocker, Léon Beyer et al. JAMA Network Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernd Holleczek Germany	48	2.6k	1.7k	1.2k	1.2k	1.1k	237	8.0k
Marilyn L. Kwan United States	53	4.6k 1.7×	1.4k 0.8×	1.8k 1.4×	1.0k 0.9×	697 0.6×	197	8.9k
Eva Skovlund Norway	47	3.9k 1.5×	765 0.4×	861 0.7×	1.9k 1.6×	1.3k 1.2×	253	9.0k
Claudio Luchini Italy	40	2.8k 1.0×	968 0.6×	1.4k 1.1×	1.2k 1.0×	758 0.7×	206	7.3k
Sunita Ghosh Canada	41	2.3k 0.9×	1.3k 0.7×	3.1k 2.5×	1.7k 1.4×	422 0.4×	436	8.8k
Lina Jansen Germany	45	4.3k 1.6×	1.1k 0.6×	441 0.4×	1.4k 1.2×	1.2k 1.1×	194	7.3k
Amylou C. Dueck United States	52	5.0k 1.9×	1.5k 0.9×	869 0.7×	1.6k 1.3×	545 0.5×	353	11.0k
Amy J. Davidoff United States	46	1.4k 0.5×	1.7k 1.0×	645 0.5×	589 0.5×	490 0.4×	231	7.4k
Hyunsoon Cho South Korea	29	2.8k 1.1×	1.5k 0.9×	478 0.4×	1.6k 1.3×	478 0.4×	83	6.8k
William P. Tew United States	44	3.3k 1.2×	1.1k 0.7×	1.5k 1.3×	1.6k 1.4×	566 0.5×	217	9.3k
Jane L. Meza United States	44	1.7k 0.6×	1.6k 0.9×	399 0.3×	2.2k 1.8×	1.1k 1.0×	178	7.0k

Countries citing papers authored by Bernd Holleczek

Since Specialization

Citations

This map shows the geographic impact of Bernd Holleczek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Holleczek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Holleczek more than expected).

Fields of papers citing papers by Bernd Holleczek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Holleczek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Holleczek. The network helps show where Bernd Holleczek may publish in the future.

Co-authorship network of co-authors of Bernd Holleczek

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Holleczek. A scholar is included among the top collaborators of Bernd Holleczek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Holleczek. Bernd Holleczek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Ruijie, Sha Sha, Lei Peng, et al.. (2025). Metabolomics data improve 10-year cardiovascular risk prediction with the SCORE2 algorithm for the general population without cardiovascular disease or diabetes. European Journal of Preventive Cardiology. 1 indexed citations

Perna, Laura, Hannah Stocker, Léon Beyer, et al.. (2023). Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study. Alzheimer s Research & Therapy. 15(1). 198–198. 9 indexed citations

Thong, Melissa S. Y., Daniela Doege, Lena Koch‐Gallenkamp, et al.. (2023). Persisting Deficits in Health-Related Quality of Life of Colorectal Cancer Survivors 14–24 Years Post-Diagnosis: A Population-Based Study. Current Oncology. 30(3). 3373–3390. 5 indexed citations

Perna, Laura, Ute Mons, Hannah Stocker, et al.. (2023). High cholesterol levels change the association of biomarkers of neurodegenerative diseases with dementia risk: Findings from a population‐based cohort. Alzheimer s & Dementia. 19(7). 2913–2922. 5 indexed citations

Stocker, Hannah, Kira Trares, Léon Beyer, et al.. (2023). Alzheimer’s polygenic risk scores, APOE, Alzheimer’s disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years. Alzheimer s Research & Therapy. 15(1). 24 indexed citations

Yang, Keyi, Daniela Doege, Melissa S. Y. Thong, et al.. (2023). Diabetes mellitus in long‐term survivors with colorectal, breast, or prostate cancer: Prevalence and prognosis. A population‐based study. Cancer. 130(7). 1158–1170. 3 indexed citations

Stocker, Hannah, Léon Beyer, Kira Trares, et al.. (2023). Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers. JAMA Network Open. 6(1). e2252387–e2252387. 66 indexed citations breakdown →

Katalinic, Alexander, Martin Meyer, Maren Pflüger, et al.. (2023). Population-Based Clinical Cancer Registration in Germany. Cancers. 15(15). 3934–3934. 25 indexed citations

Neis, Felix, et al.. (2022). Proposal for a descriptive and differentiated presentation of the longitudinal impact of the new organized cancer screening guideline and HPV vaccination in Germany. Archives of Gynecology and Obstetrics. 307(4). 1125–1136. 3 indexed citations

10.

Li, Xiangwei, Ben Schöttker, Bernd Holleczek, & Hermann Brenner. (2022). Associations of DNA methylation algorithms of aging and cancer risk: Results from a prospective cohort study. EBioMedicine. 81. 104083–104083. 18 indexed citations

11.

Kajüter, Hiltraud, et al.. (2021). Colorectal Cancer among Resettlers from the Former Soviet Union and in the General German Population: Clinical and Pathological Characteristics and Trends. International Journal of Environmental Research and Public Health. 18(9). 4547–4547. 1 indexed citations

12.

Guo, Feng, Chen Chen, Bernd Holleczek, et al.. (2021). Strong Reduction of Colorectal Cancer Incidence and Mortality After Screening Colonoscopy: Prospective Cohort Study From Germany. The American Journal of Gastroenterology. 116(5). 967–975. 41 indexed citations

13.

Doege, Daniela, Melissa S. Y. Thong, Lena Koch‐Gallenkamp, et al.. (2021). Distress mediates the relationship between cognitive appraisal of medical care and benefit finding/posttraumatic growth in long‐term cancer survivors. Cancer. 127(19). 3680–3690. 5 indexed citations

14.

Doege, Daniela, Melissa S. Y. Thong, Lena Koch‐Gallenkamp, et al.. (2020). Age‐specific prevalence and determinants of depression in long‐term breast cancer survivors compared to female population controls. Cancer Medicine. 9(22). 8713–8721. 21 indexed citations

15.

Koch‐Gallenkamp, Lena, Heike Bertram, Andrea Eberle, et al.. (2019). Health‐related quality of life in long‐term survivors with localised prostate cancer by therapy—Results from a population‐based study. European Journal of Cancer Care. 28(5). e13076–e13076. 18 indexed citations

16.

Leiter, Ulrike, Ulrike Keim, Thomas Eigentler, et al.. (2017). Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany. Journal of Investigative Dermatology. 137(9). 1860–1867. 140 indexed citations

17.

Zhang, Yan, Magdeldin Elgizouli, Ben Schöttker, et al.. (2016). Smoking-associated DNA methylation markers predict lung cancer incidence. Clinical Epigenetics. 8(1). 127–127. 98 indexed citations

18.

Koch‐Gallenkamp, Lena, Heike Bertram, Andrea Eberle, et al.. (2016). Fear of recurrence in long-term cancer survivors—Do cancer type, sex, time since diagnosis, and social support matter?. Health Psychology. 35(12). 1329–1333. 90 indexed citations

19.

Ordóñez-Mena, José M, Ben Schöttker, Ulrike Haug, et al.. (2013). Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results from a Large German Prospective Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 22(5). 905–916. 57 indexed citations

20.

Holleczek, Bernd, Lina Jansen, & Hermann Brenner. (2013). Breast Cancer Survival in Germany: A Population-Based High Resolution Study from Saarland. PLoS ONE. 8(7). e70680–e70680. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact